The FINANCIAL --The Cambridge COVID-19 Testing Centre, set up in April in response to the urgent need to boost the UK’s testing capabilities, has processed two million tests.
More
The FINANCIAL -- Injecting a gene therapy vector into one eye of someone suffering from LHON, the most common cause of mitochondrial blindness, significantly improves vision in both eyes, scientists have found. In a landmark phase 3 clinical trial, the international team, coordinated
More